These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

173 related articles for article (PubMed ID: 20443750)

  • 1. Emerging drugs for renal cell carcinoma.
    Varella L; Rini BI
    Expert Opin Emerg Drugs; 2010 Sep; 15(3):343-53. PubMed ID: 20443750
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Treatment of metastatic renal cell carcinoma.
    Reeves DJ; Liu CY
    Cancer Chemother Pharmacol; 2009 Jun; 64(1):11-25. PubMed ID: 19343348
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Update on novel agents in renal cell carcinoma.
    Tamaskar I; Pili R
    Expert Rev Anticancer Ther; 2009 Dec; 9(12):1817-27. PubMed ID: 19954293
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinical effect and future considerations for molecularly-targeted therapy in renal cell carcinoma.
    Rini BI; Flaherty K
    Urol Oncol; 2008; 26(5):543-9. PubMed ID: 18774471
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Systemic therapy for sarcomatoid renal cell carcinoma.
    Pagliaro LC; Tannir N; Sircar K; Jonasch E
    Expert Rev Anticancer Ther; 2011 Jun; 11(6):913-20. PubMed ID: 21707288
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Emerging drugs for renal cell carcinoma.
    Shaheen PE; Bukowski RM
    Expert Opin Emerg Drugs; 2005 Nov; 10(4):773-95. PubMed ID: 16262562
    [TBL] [Abstract][Full Text] [Related]  

  • 7. What is new in kidney cancer?
    Kirkali Z
    Expert Rev Anticancer Ther; 2009 Dec; 9(12):1753-5. PubMed ID: 19954286
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The end of chemotherapy in renal cell carcinoma: for much but not for all.
    Iacovelli R; Raimondi C; Palazzo A
    Am J Clin Oncol; 2010 Oct; 33(5):522-3. PubMed ID: 20924226
    [No Abstract]   [Full Text] [Related]  

  • 9. Sequential use of targeted agents in the treatment of renal cell carcinoma.
    Hutson TE; Bukowski RM; Cowey CL; Figlin R; Escudier B; Sternberg CN
    Crit Rev Oncol Hematol; 2011 Jan; 77(1):48-62. PubMed ID: 20705477
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Targeted therapy of renal cell cancer.
    Wysocki PJ; Zolnierek J; Szczylik C; Mackiewicz A
    Curr Opin Investig Drugs; 2008 Jun; 9(6):570-5. PubMed ID: 18516756
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Molecularly targeted agents for renal cell carcinoma: the next generation.
    Cowey CL; Hutson TE
    Clin Adv Hematol Oncol; 2010 May; 8(5):357-60, 361-4. PubMed ID: 20551895
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Novel therapeutics for metastatic renal cell carcinoma.
    Hutson TE; Figlin RA
    Cancer; 2009 May; 115(10 Suppl):2361-7. PubMed ID: 19402059
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Toxicity associated with the long-term use of targeted therapies in patients with advanced renal cell carcinoma.
    Shepard DR; Garcia JA
    Expert Rev Anticancer Ther; 2009 Jun; 9(6):795-805. PubMed ID: 19496716
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Targeted therapy for cytokine-refractory metastatic renal cell carcinoma, and treatment in the community.
    Bukowski RM
    Oncology (Williston Park); 2006 May; 20(6 Suppl 5):25-8. PubMed ID: 16773842
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Molecular targeted therapy for advanced renal cell carcinoma].
    Kanayama H
    Gan To Kagaku Ryoho; 2010 Jul; 37(7):1208-13. PubMed ID: 20647700
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Temsirolimus, an mTOR inhibitor for treatment of patients with advanced renal cell carcinoma.
    Malizzia LJ; Hsu A
    Clin J Oncol Nurs; 2008 Aug; 12(4):639-46. PubMed ID: 18676330
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Targeted therapy and hand-foot skin reaction in advanced renal cell carcinoma.
    Yang CH; Chuang CK; Hsieh JJ; Chang JW
    Expert Opin Drug Saf; 2010 May; 9(3):459-70. PubMed ID: 20113155
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Screening for and identification of novel agents directed at renal cell carcinoma.
    Mertins SD; Myers TG; Hollingshead M; Dykes D; Bodde E; Tsai P; Jefferis CA; Gupta R; Linehan WM; Alley M; Bates SE
    Clin Cancer Res; 2001 Mar; 7(3):620-33. PubMed ID: 11297258
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Another step toward the cure of metastatic renal cell carcinoma?
    Vogelzang NJ
    J Clin Oncol; 2010 Dec; 28(34):5017-9. PubMed ID: 20975069
    [No Abstract]   [Full Text] [Related]  

  • 20. Targeted therapy for renal cell carcinoma: a new therapeutic paradigm.
    Shaheen PE; Bukowski RM
    Cancer Invest; 2006 Oct; 24(6):640-56. PubMed ID: 16982470
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.